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It has been suggested that the supernatant of LPS-
stimulated macrophages (macrophage nociceptive
factor, MNF) promotes nociception in mice. In-
traperitoneal administration of MNF induced
dose-related writhing, which reached a plateau
between 18 and 26 min after injection and de-
creased within 60 min. The release of MNF was
inhibited by the pretreatment of the macrophages
with cycloheximide, a protein synthesis inhibitor,
or with the glucocorticoid dexamethasone. Cyclo-
oxygenase inhibitors, such as indomethacin or
paracetamol, had no effect. The MNF-induced
nociception was inhibited in a dose-related man-
ner by pretreatment of the animals with indo-
methacin, paracetamol or dexamethasone.
Pretreatment of the animals with the sympatholy-
tics guanethidine and atenolol partially reduced
the MNF nociception, which was abolished by the
combination of guanethidine or atenolol with
indomethacin. The preincubation of MNF with
antisera against TNF-a, IL-1 or IL-8 partially in-
hibited its nociceptive effect. Intraperitoneal in-
jection of a mixture of the recombinants
cytokines TNF-a, IL-1 and IL-8 mimicked MNF
nociception. The individual injection of these
cytokines was unable to induce the nociceptive
effect. In conclusion, our data suggest that the
nociceptive activity of the supernatant of LPS-
stimulated macrophages is explained by the pre-
sence of TNF-a, IL-1 and IL-8, the nociceptive
activity of which (in mice) seems to be due to the
release of cyclooxygenase and sympathetic meta-
bolites.
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Introduction
It has been proposed that two biochemical
pathways are involved in in￿ammatory pain
which are dependent on the release of cyclo-
oxygenase (mainly PGE2 and PGI2) or sympa-
thetic metabolites (mainly dopamine), respec-
tively. It is assumed that the contribution of
each pathway depends on the characteristics of
the nociceptive stimulus. These two compo-
nents were demonstrated in rats using a paw
pressure test,1 in mice using the writhing test,2
and in guinea pigs by nociception evoked by
electrical stimulation.3
Cytokines seem to constitute a link between
cellular injury and recognition of non-self and
the development of local and systemic in-
￿ammatory signs and symptoms (e.g. cell
migration, oedema, fever and hyperalgesia4- 8).
In this context, we have recently demon-
strated that in carrageenan-evoked hyperalgesia,
a cascade of cytokine release preceded the
generation of cyclooxygenase products and
sympathomimetic mediators.5,9,10 It was sug-
gested that the initial cytokine released is TNF-a
which induces either: IL-1b and IL-6 release,
which in turn stimulate the production of cyclo-
oxygenase products; or IL-8 release which
stimulates production of sympathomimetic med-
iators.10
We have previously shown that macrophage
monolayers stimulated with endotoxin (LPS)
release a factor with an apparent MW greater
than 10 kDa into the culture medium which,
when injected intraperitoneally into mice, in-
duced writhing. This macrophage nociceptive
factor was referred to as MNF; induction of
writhing by MNF was inhibited by pretreatment
of mice with indomethacin; dipyrone, but not
indomethacin, blocked its release by LPS-stimu-
lated macrophage monolayers.11
In the present study we investigated the
effect of the cyclooxygenase inhibitor paraceta-
mol and the glucocorticoid dexamethasone on
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monolayers.11 The effect of indomethacin and
paracetamol, as well as sympatholytic agents,
such as atenolol and guanethidine, on MNF-
induced nociception was also determined to
investigate the involvement of cytokines in MNF
activity; we tested the effect of antibodies
against TNF-a, IL-1b or IL-8 on MNF nociceptive
activity.
Materials and Methods
Animals
Male Wistar rats, 150±180 g body weight, were
used to obtain the peritoneal macrophages, and
male Swiss mice, 20±25 g bodyweight, were
used for the nociceptive test. The animals were
housed in a temperature controlled room
(23 28 C) with free access to water and food.
The ethical guidelines as described in the NIH
Guide for the Care and Use of Laboratory
Animals was followed throughout the experi-
ments described.
MNF production
Peritoneal macrophages were obtained from
Wistar rats 4 days after intraperitoneal (i.p.)
injection of 10 ml thioglycollate (3%w/v). The
cells were harvested with 10 ml of RPMI med-
ium and allowed to adhere to plastic tissue
culture dishes for 1 h at 378 C(2 0·2 3 106), in
a CO2 incubator as previously described.11 After
1 h of incubation, non-adherent cells were
removed by washing three times with phos-
phate buffered saline (PBS) pH 7.4. The ad-
herent population, consisting of 95 2%
macrophages (determined by conventional light
microscopy after staining with Rosenfeld pan-
cromic stain), was then incubated for 30 min at
378 C in fresh medium (control) or medium
containing 5 mg/ml of Escherichia coli lipopoly-
saccharide (LPS). The supernatant was dis-
carded and the monolayers were washed three
times with PBS and then incubated for 1 h in
4 ml of medium without LPS. At the end of
incubation the viability of the macrophages was
determined by trypan blue exclusion (viability
higher than 90% ) and the cell-free incubation
￿uids were ultra￿ltered through an Amicon YM-
10 membrane (which restricts substances of a
molecular weight greater than 10 kDa). The
residue retained by the membrane was washed
with PBS and dilutions were made in order to
obtain a solution in which 1 ml originated from
4 3 106 macrophages. On the basis of its bio-
logical action, the material obtained (as de-
scribed above) is referred to as macrophage
nociceptive factor (MNF).
Nociceptive test
The nociceptive activity of MNF was tested in
mice using the writhing model.12 For this
purpose, 0·1 ml/g body weight of MNF solution
was injected into the peritoneal cavity of the
test animals. The intensity of nociception was
quanti￿ed by counting the total number of
writhes occurring between 14 and 34 min after
MNF injection. In the experiment, in which the
time course of MNF activity was determined,
the number of writhes was counted between
10 and 50 min.
Effect of different drugs on MNF
release and on its nociceptive activity
The effects of indomethacin (10- 5 M and
10- 4 M) paracetamol (10- 4 M) dexamethasone
(10- 5 M) and cyclohexamide (10- 5 M and
3 3 10- 5 M) on MNF release in vitro were
tested by adding these drugs to the incubation
￿uid 30 min before LPS challenge of the macro-
phage monolayers. During the LPS stimulation
periods as well as during the incubation period,
the drugs were also present. The possible effect
of these drugs present in the supernatant of the
writhing response could be disregarded, since
the supernatants were ultra￿ltered on an Ami-
con YM-10 membrane before being injected
into the animals.
The effects of indomethacin (0.5 and
2·0 mg/kg, 30 min before), paracetamol (100
and 200 mg/kg, 30 min before), atenolol
(0·5 mg/kg, 30 min before), and dexametha-
sone (0.5 and 2·0 mg/kg, 30 min before) on
MNF-induced nociception were tested, treating
the animals by subcutaneous (s.c.) injection.
To investigate the effect of guanethidine
(30 mg/kg) on MNF activity, the animals were
pretreated daily by the s.c. route for 3 days
before MNFinjection.
Effects of anti-cytokine sera on MNF
activity
The antisera (anti-human IL-1b, anti-murine
TNF-a, anti-human IL-8) and the control serum
were incubated with MNF solution for 10 min
before injection of the mixture into the test
mice. In an earlier experiment, we demon-
strated that these anti-sera neutralized the hy-
peralgesic effects of their respective rat
cytokines. 10
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IL-8
TNF-a (0·5- 100 ng/mouse), IL-1b (0·005-
100 ng/mouse) and IL-8 (0·1- 50 ng/mouse)
were injected i.p. into the test mice and the
number of writhes was determined between 14
and 34 min afterwards. The effects of the
combination of these cytokines (100 ng of
IL-1+ 100 ng of TNF-a+ 50 ng of IL-8 per
mouse), and their dilutions (1:3 and 1:9) were
also tested.
Drugs, reagents and antisera
The following drugs were used: atenolol (Sigma,
USA; Atn); bradykinin (Sigma, USA; BK); cyclo-
heximide (Sigma, USA; CHX); dexamethasone
(Merck, Sharp and Dohme, USA; Dexa); endo-
toxin (E. coli lipopolysaccaride; Difco, USA;
LPS); guanethidine (Sigma, USA; Gua); indo-
methacin (Merck, Sharp and Dohme, ISA; Indo);
paracetamol (Sigma, USA; Ptol); thioglycolate
(Difco, USA). The medium used was RPMI 1640
(Difco, USA). TNF-a, IL-1b and IL-8 (72 amino
acids) were NIBSC preparations coded 87/650,
86/680 and 89/520, respectively. The following
antisera were used: sheep anti-human IL-1b
(Poole et al., 198913), sheep anti-human IL-8
(Cunha et al., 19919) and sheep anti-murine
TNF-a (Mahadevan et al., 199014); these were
kindly provided by Dr S. Poole (NIBSC, England,
UK).
Statistical analysis
Analysis of variance (ANOVA) followed by Bon-
ferroni’s test were used. Statistical differences
were considered to be signi￿cant at P , 0·05.
Results
Nociceptive effect of LPS-stimulated
macrophage supernatant (MNF)
The i.p. injection of supernatant from rat
macrophage monolayers incubated at 378 Cwith
LPS (5 mg/ml) into mice induced a dose-related
nociception, which reached the plateau be-
tween 18 and 26 min after injection (Fig. 1A).
Supernatants obtained from non-stimulated
macrophages or from LPS-stimulated macro-
phages incubated at 48 C, did not induce the
nociceptive response (Fig. 1B). Similar results
were obtained with the supernatant of the mice
macrophages stimulated with LPS (data not
shown).
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FIG. 1. Nociceptive effect of the supernatant of LPS-stimulated macrophages (MNF, macrophage nociceptive factor).
(A) Time course (10- 50 min) of the nociceptive response induced by different doses of MNF: n , 1 ml/g body weight;
d , 0·1 ml/g; s , 0·01 ml/g). The insert in (A) shows the total number of writhes determined in the interval between 14 and
34 min after injection of MNF at doses of 0·01 ml/g body weight [1], 0·1 ml/g [5] and 1 ml/g [10]. (B) Number of writhes
induced by i.p. injeciton of: SAL, saline; RPMI, supernatant of macrophages incubated with medium alone; LPS 48 C/LPS
378 C, supernatant of macrophages stimulated for 30 min with LPS (5 mg/ml) and incubated at 48 C or at 378 C (0·1 ml/g body
weight). The number of writhes was determined in the interval between 14 and 34 min after MNF injection. In all panels the
number at the top of each bar represents the number of mice in that experimental group. The results are reported as
means SEM. , Statistically signi® cant differences (P , 0·05) between the group and the control group (SAL) determined
by ANOVA and Bonferroni’s test.
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TNF-a, IL-1, IL-8 and nociceptionEffects of cycloheximide,
dexamethasone, indomethacin and
paracetamol on MNF release
The treatment of macrophage monolayers with
the protein synthesis inhibitor cycloheximide
(10- 5, 3 3 10- 5 M) or with the glucocorticoid
dexamethasone (10- 5 M), but not with the
cyclooxygenase inhibitors, indomethacin
(10- 5- 10- 4 M) or paracetamol (10- 4 M), dimin-
ished MNF activity in LPS-stimulated macro-
phage supernatants (Fig. 2).
Effects of cyclooxygenase inhibitors,
sympathetic blockers and
dexamethasone on MNF activity
The subcutaneous administration of indometh-
acin (0.5 and 2·0 mg/kg), paracetamol (100 and
200 mg/kg) or dexamethasone (0.5 and
2·0 mg/kg) inhibited the nociception induced
by MNF (Fig. 3A). Fig. 3B shows that although
the sympathetic blockers guanethidine (Gua,
30 mg/kg, daily) and atenolol (Atn, 0·5 mg/kg)
partially inhibited the nociceptive effect of MNF ,
the effects were not signi￿cant. However, the
combination of guanethidine or atenolol with a
dose of indomethacin (0·5 mg/kg), that partially
inhibited MNF activity, abolished the nocicep-
tive effect of MNF (Fig. 3C). The administration
of the higher doses of the drugs used (indo-
methacin, paracetamol, guanethidine, atenolol
or dexamethasone) in normal animals did not
promote any behavioural alteration.
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FIG. 3. Effects of indomethacin, paracetamol, dexamethasone, guanethidine and atenolol on MNF-induced writhing in mice.
(A) Number of writhes induced by MNF in untreated mice (MNF, i.p., 0·1 ml/g body weight) and in mice pretreated s.c. with
the indicated doses (mg/body weight) of indomethacin (Indo, 30 min before), paracetamol (Ptol, 30 min before) or
dexamethasone (Dexa, 60 min before) (B) Number of writhes induced by MNF in untreated mice (MNF, i.p., 0·1 ml/g body
weight) and in mice pretreated by s.c. injection of guanethidine (Gua, 30 mg/kg) or atenolol (Atn, 0·5 mg/kg) 30 min before
injection of the nociceptive stimulus (MNF). (C) Number of writhes induced by MNF in untreated mice (MNF, i.p., 0·1 ml/g
body weight) and in mice pretreated by s.c. injection of the association of guanethidine (Gua, 30 mg/kg) and indomethacin
(Indo, 0·5 mg/kg) and atenolol (Atn, 0·5 mg/kg) 30 min before the injection of the nociceptive stimulus (MNF). The values are
reported as means SEM of the total number of writhes occurring between 14 and 34 min after challenge with MNF. The
number at the top of each bar represents the number of mice in that group. , Statistically signi® cant differences (P , 0·05)
from the control group determined by ANOVA and Bonferroni’s test.
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FIG. 2. Effects of indomethacin, paracetamol, cycloheximide
and dexamethasone on MNF release. The bars show the
number of writhes induced by the supernatant (0·1 ml/g
body weight, i.p.) from LPS-pretreated macrophages in the
absence (MNF) or the presence of the indicated concentra-
tion (M) of indomethacin (Indo), paracetamol (Ptol), cyclo-
heximide (CHX) or dexamethasone (Dexa). The number at
the top of each bar represents the number of mice in that
group. The values are reported as means SEM of the
total number of writhes occurring between 14 and 34 min
after MNF injection. , Statistically signi® cant differences
(P , 0·05) from the control group determined by ANOVA
and Bonferroni’s test).
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on the nociceptive activity of MNF
Preincubation of MNF with antisera (50 ml)
against IL-8, IL-1b or TNF-a signi￿cantly inhib-
ited its nociceptive activity. Control serum did
not affect MNF activity (Fig. 4). Antiserum
against IL-6 did not affect MNF-activity.
Nociceptive effects of IL-1b, IL-8 and
TNF-a
Intraperitoneal injection of different doses of
IL-1 (0·005- 100 ng/mouse), IL-8 (0·1- 50 ng/
mouse) or TNF-a (0·5- 100 ng/mouse) did not
induce signi￿cant nociceptive responses in
mice. However, like MNF , the combination of
these cytokines (100 ng of TNF-a and IL-1 plus
50 ng IL-8) induced a signi￿cant nociceptive
response. This combination, when diluted 3- or
9-fold, induced only small nociceptive response
(Fig. 5).
Discussion
We have con￿rmed our previous results show-
ing that macrophage monolayers stimulated
with LPS (5 mg/ml) at 378 C release a nocicep-
tive factor (MNF) into the supernatant that
induces dose-dependent writhing in mice.12 The
absence of the nociceptive activity in the super-
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FIG. 5. The nociceptive effects of IL-1b, IL-8, TNF-a or their mixture. The mice were injected with PBS, MNF, and indicated
doses (ng/mouse) of IL-1, IL-8, and TNF-a or with three doses of the mixture of these three cytokines. The highest dose of
the mixture was 100 ng/mouse IL-1b+ 50 ng/mouse IL-8+ 100 ng/mouse TNF-a (1:1); this was then used to prepare 1:3 or
1:9 dilutions. The number of writhes was determined in the interval between 14 and 34 min after the stimulus injection. The
number at the top of each bar represents the number of mice in that group. The values are reported as means SEM. ,
Statistically signi® cant differences (P , 0·05) from the negative control (PBS) determined by ANOVA and Bonferroni’s test.
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FIG. 4. Effect of antisera against TNF-a, IL-1b or IL-8 on the
nociception induced by MNF. The MNF samples were
incubated with 50 ml of the anti-cytokine sera or with control
serum for 10 min and then injected i.p. The values are
reported as means SEM of the total number of writhes
occurring between 14 and 34 min after challenge with MNF
alone or in combination with the sera. PBS, number of
writhes induced by PBS. The number at the top of each bar
represents the number of mice in that group. , Statistically
signi® cant differences (P , 0·05) from the positive control
group (MNF) determined by ANOVA and Bonferroni’s test.
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were incubated at 48 C eliminates the possibility
that the observed effect is due to LPS contam-
ination. The nociceptive activity of MNF
reached a plateau between 18 and 26 min, and
decreased thereafter.
It was also con￿rmed that MNF is not a
cyclooxygeanse product,11 since the cyclooxy-
genase inhibitors, indomethacin or paracetamol,
did not affect its release. Furthermore, the
presence of arachidonic acid metabolites in the
MNF preparation could be disregarded since the
ultra￿ltration step used in the preparation of
MNF excludes substances with a MW smaller
than 10 kDa. The fact that the protein synthesis
inhibitor cycloheximide and the glucocorticoid
dexamethasone blocked the release of MNF by
LPS-stimulated macrophages suggests that it is a
protein. Since glucocorticoids are classical in-
hibitors of cytokine activity, and LPS-stimulated
macrophages release various cytokines, includ-
ing IL-1, IL-8 and TNF-a, which promote
hyperalgesia,9,10 we investigated the possibility
that the MNF activity is due to the presence of
these cytokines in the MNF samples. Using an
effective concentration of antiserum against IL-
1, IL-8 or TNF-a,9,10 we observed that all the
sera tested partially inhibited the nociceptive
activity of MNF , suggesting that MNF activity
may be due to the combined nociceptive
activities of IL-1, IL-8 and TNF-a present in the
MNF samples. The presence of these cytokines
in the supernatants of LPS-stimulated macro-
phages used to prepare MNF has been
described.15,16 The possibility that MNF activity
results from the combination of these three
cytokines was tested by injection of different
concentrations of these cytokines alone or in
combination into the abdominal cavity of mice.
Although IL-1, IL-8 and TNF-a injected singly at
high doses were unable to promote a signi￿cant
nociception in mice, injection in combination
reproduced the MNF-induced nociception.
The nociception caused by MNF was blocked
in a dose-dependent manner by the cyclooxy-
genase inhibitors indomethacin and paraceta-
mol, as well as by dexamethasone. The
sympathetic blockers guanethidine and atenolol
also partially reduced the effect of MNF , and
their combination with a low dose of indometh-
acin abolished MNF nociception. These results
indicate that nociception induced by MNFis the
result of the local release of sympathetic and
cyclooxygenase mediators. The data show, how-
ever, that the presence of cyclooxygenase meta-
bolites are essential triggering MNF activity,
since indomethacin and paracetamol abolished
MNF nociception. The inhibition by dexametha-
sone of MNF activity can be explained by its
ability to block the release of prostaglandin via
inhibition of phospholipase A2,17,18 as well as
the expression of cyclooxygenase 2.19
In conclusion, we demonstrated that the
nociceptive activity of the supernatant of LPS-
stimulated macrophages may be due to the
presence of IL-1, IL-8 and TNF-a. These cyto-
kines induce nociception mainly by the activa-
tion of the prostaglandin component of
in￿ammatory pain, although the activation of
sympathetic components may be also involved.
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